In vivo and in vitro, our data after Dox-treated have shown that with the increase of ROS generation, and endothelial dysfunction, eNOS expression decreased, especially eNOS phosphory-lation, and thereby NO content decreased. The gene discussed is NOS3; the disease is endothelial dysfunction.